Effective multifunctional therapeutic agents
Research gap analysis derived from 3 chemistry papers in our local library.
The gap
There is a need for effective multifunctional therapeutic agents for the treatment of blood cancers and bacterial infections. Conventional treatment strategies have limitations such as drug resistance and systemic toxicity.
Evidence profile
Sourced from the stated research gap of the source papers, classified as general, drawn from work published between 2024 and 2026, spanning 3 journals. Those papers have been cited 6 times in total.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- IN SILICO MOLECULAR DOCKING STUDIES OF NOVEL 1,3,4-OXADIAZOLE DERIVATIVES AS POTENT MULTI-TARGET AGENTS: EXPLORING ANTIMICROBIAL, ANTICANCER, ANTIFUNGAL, AND ANTI-INFLAMMATORY POTENTIAL (2026) · European Journal Pharmaceutical and Medical Research · doi
The rising prevalence of multidrug-resistant pathogens and complex diseases necessitates the development of multi-target therapeutic agents. The lack of effective therapeutic agents for the treatment of cancer, bacterial/fungal infections, and inflammation highlights the need for novel approaches.
generalstated research gapevidence 5/5Keywords: rising prevalence multidrug-resistant pathogens complex diseases necessitates development - Biocompatible pluronic F127 coated TiO₂/ZnTiO₃ hybrid nanomaterial: Structural insights and bioactivity against bacteria and blood cancer cells (2026) · Journal of Sol-Gel Science and Technology · doi
There is a need for effective multifunctional therapeutic agents for the treatment of blood cancers and bacterial infections. Conventional treatment strategies have limitations such as drug resistance and systemic toxicity.
generalstated research gapevidence 5/5Keywords: there need effective multifunctional therapeutic agents treatment blood - Molecular docking, ADMET, synthesis and evaluation of new indomethacin hydrazide derivatives as antibacterial agents (2024) · Pharmacia · cited 6× · doi
The prevalence of drug-resistant bacterial pathogen strains reduces current therapies' efficacy and increases the risk of developing new bacterial infections. There is a need for novel, low-toxic medications that are both effective and have unique mechanisms of action.
generalstated research gapevidence 5/5Keywords: prevalence drug-resistant bacterial pathogen strains reduces current therapies
Questions about this gap
Explore this gap further
Run this gap as a query across open scholarly engines for the latest related literature.
Working on this gap? Review it with us.
Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.
Tools for your next paper
Related gaps in Chemistry
- The findings demonstrate that metal complexationThe findings demonstrate that metal complexation significantly improves antimicrobial potency compared to the free ligand and support furthe…
- The development of efficient inhibitor systems capableThe development of efficient inhibitor systems capable of ensuring high protection performance in strongly acidic media. The need to underst…
- Investigate the in vivo efficacy of the compounds, -Investigate the in vivo efficacy of the compounds, - The study did not examine the potential toxicity of the compounds to non-target organis…
- The paper identifies the need for a sustainableThe paper identifies the need for a sustainable and eco-friendly alternative to conventional nanoparticle synthesis methods. The gap in the …